New research explains why metastatic uveal melanoma is resistant to conventional immunotherapies and how adoptive therapy, which involves growing a patient’s T cells outside the body before reinfusing them, can successfully treat this rare and aggressive cancer.
Lesen Sie weiter auf: New insights could unlock immunotherapy for rare, deadly eye cancer
Quelle: ScienceDaily | Immune System
Titelbild/Grafik by ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Novel study reveals how aging immune system fuels cancer growth, potentially opening new avenues for prevention
- Cause, potential treatments ID'd for persistent COVID-19 lung problems
- Skin fungus colonization accelerates breast cancer tumor growth
- Researchers identify mechanism underlying allergic itching, and show it can be blocked
- Researchers reveal key LAG3 mechanisms that could transform cancer immunotherapy
- Investigational mpox mRNA vaccine reduces disease severity in primates compared to available vaccines
- Novel immunotherapy improves recovery from spinal cord injury
- Sex hormones modulate the immune system to influence disease risk differently, study finds
- Inflammation leaves a long-lasting impression on intestinal stem cells that reduces their ability to heal
- Scientists identify potential new immune system target to head off the spread of breast cancer cells
